QC
AGN

Quadrature Capital’s Allergan plc AGN Stock Holding History

Quadrature Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-33,254
Closed -$6.33M – 782
2018
Q3 		$6.33M Buy
33,254
+15,549
+88% +$2.86M 0.52% 43
2018
Q2 		$2.95M Buy
+17,705
New +$2.84M 0.28% 100
2018
Q1 		– Sell
-84,206
Closed -$13.8M – 817
2017
Q4 		$13.8M Buy
+84,206
New +$15.1M 1.22% 11
2017
Q3 		– Sell
-43,969
Closed -$10.7M – 720
2017
Q2 		$10.7M Buy
+43,969
New +$10.3M 0.82% 22
2016
Q4 		– Sell
-79,953
Closed -$18.4M – 855
2016
Q3 		$18.4M Buy
+79,953
New +$19.5M 1.6% 7

Other funds holding AGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Quadrature Capital's AGN Position: Q4 2018 in Review

Quadrature Capital sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 33,254 shares — an estimated $6.33M sold.

Quadrature Capital first reported a position in AGN in Q3 2016 and held it in 5 quarters. The position peaked at $18.4M in Q3 2016. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.

  • Quadrature Capital reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
  • Quadrature Capital sold 33,254 Allergan plc shares in Q4 2018, an estimated $6.33M.
  • Quadrature Capital first reported a position in Allergan plc in Q3 2016 and held it in 5 quarters.
  • Quadrature Capital's Allergan plc position peaked at $18.4M in Q3 2016.
  • 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.

Based on Quadrature Capital's 13F filing for Q4 2018, filed 13 Feb 2019.